Imatinib mesylate inhibits platelet-derived growth factor activity and increases chemosensitivity in feline vaccine-associated sarcoma

By Katayama Rieko   Huelsmeyer Michael   Marr Amanda   Kurzman Ilene   Thamm Douglas   Vail David  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 1, 2004-07 ,pp. : 25-33

Springer Publishing Company

Access to resources Recommend Favorite

Management of skin toxicity related to the use of imatinib mesylate

By Scott Lucy C.  

Sarcoma, Vol. 9, Iss. 3-4, 2005-09 ,pp. : 157-160

Informa Healthcare

Access to resources Recommend Favorite

Imatinib Mesylate: Targeted Therapy of Gastrointestinal Stromal Tumor

By  

Current Cancer Therapy Reviews, Vol. 1, Iss. 1, 2005-01 ,pp. : 93-108

Bentham Science Publishers

Access to resources Recommend Favorite

Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors

By Tonyali Onder   Coskun Ugur   Yildiz Ramazan   Karakan Tarkan   Demirci Umut   Akyurek Nalan   Benekli Mustafa   Buyukberber Suleyman  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 768-773

Humana Press, Inc

Access to resources Recommend Favorite

Imatinib Mesylate: A Review of Its Use in Chronic Myeloid Leukemia

By Curran M.P.   Croom K.F.   Goa K.L.  

American Journal of Cancer, Vol. 2, Iss. 6, 2003-01 ,pp. : 439-454

Adis International

Access to resources Recommend Favorite